Project Grant R41GM156145

Award Date 9/16/24
Completion Date 8/31/25
Dollars Obligated $307K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
West Newton, MA 02465, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $350,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Fluidispec LLC in Philadelphia, PA. The grant will fund the development of a new microfluidic/nanofluidic sample preparation platform to improve protein extraction, purification, and denaturation for top-down and bottom-up proteomics workflows. The system aims to enhance the depth of proteome coverage and speed of single-cell proteomics...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports the development of a sensor-like liquid chromatography-mass spectrometry (LC-MS) platform for rapid, real-time monitoring of targeted small molecule metabolites in complex biological systems. The $375,000 award to Rowan University will fund research focused on achieving high-throughput gradient LC separations at capillary-scale flow...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $295,561 to Biosensing Instrument Inc. to develop a commercial prototype of a multi-functional Plasmonic Scattering Microscopy (PSM) instrument. The PSM technology enables high-throughput, label-free quantification of membrane protein binding kinetics on single cells in their native microenvironment. This addresses an unmet...
The National Institute of General Medical Sciences (NIGMS) awarded a $358,862 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to GMJ Technologies, Inc., a minority-owned small business, to develop a microfluidic SDS depletion electrophoresis (SDE) interface. This interface will enable direct coupling of capillary electrophoresis with sodium dodecyl sulfate (CE-SDS) to mass spectrometry for improved characterization and quality control of monoclonal...
This $350,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of a high-resolution native capillary zone electrophoresis system with inline UV and native mass spectrometry capabilities for characterizing charge variants in biologics. The funded project aims to address critical challenges in the characterization and quality control of protein therapeutics by...
This $613,746 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) aims to develop 3D-printed microfluidic channel architectures to precisely control the structure and properties of lipid nanoparticles (LNPs) for improved nucleic acid delivery. The key objectives are to: 1) Design, simulate, and test 3D channel architectures to manipulate flow conditions and tailor LNP properties, 2)...
This $349,566 Project Grant award from the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports the development of Biosensing Instrument Inc.'s Spotting-Free Nano-Oscillator Array (SFNOA) technology. The SFNOA system aims to provide high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. Key innovations include the use...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) totaling $202,274 provides funding to Acpharis to develop an algorithm and software tool for predicting the structure and degradation efficiency of proteolysis targeting chimera (PROTAC) compounds. The key goals are to: Implement a computational protocol to accurately model PROTAC ternary complexes, including the optimal linker design to...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training program provides $349,816 to Narwhal Bio, Inc. to develop a prototype instrument, software, and consumable for non-invasive, live-cell identification, tagging, and downstream characterization. The goal is to enable researchers to study clinically relevant cell-cell interactions, which drive many challenging diseases like cancer, autoimmunity, and...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), is developing a microfluidic device for rapid and inexpensive pathogen detection in rodent animal health surveillance. The goal is to create a device that can be used cage-side to complement existing quarterly room/rack monitoring, enabling faster outbreak mitigation and health status confirmation for animal importation. The key...

This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $306,860 to Mixedlcmedia LLC to develop a commercialization-ready prototype of an ultra-low flow liquid chromatography (ULF LC) platform.

The goal is to enable deep proteomic profiling of limited biological and clinical samples, such as liquid biopsies, microneedle tissue biopsies, and rare cell isolates. This technology has the potential to enable early diagnostics and personalized treatments for deadly diseases like cancer, Alzheimer's, and cardiovascular conditions, as well as characterize cell model systems and advance fundamental biology research. The award period is from September 16, 2024 to August 31, 2025.

Generated 4/8/25, 3:26 AM